Literature DB >> 15769927

Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery.

S C Talwalkar, D M Grennan, J Gray, P Johnson, M J Hayton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15769927      PMCID： PMC1755448          DOI： 10.1136/ard.2004.028365

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  Perioperative care for patients with rheumatic diseases.

Authors:  Bharath M Akkara Veetil; Tim Bongartz
Journal:  Nat Rev Rheumatol       Date:  2011-11-15       Impact factor: 20.543

2.  Pre-operative withholding of infliximab and the risk of infections after major surgery in patients with rheumatoid arthritis.

Authors:  Michael M Ward; Abhijit Dasgupta
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580

3.  Surgery in rheumatoid arthritis patients under anti-TNF-alpha therapy: what is the risk?

Authors:  Daniel Wendling
Journal:  Clin Rheumatol       Date:  2007-02-21       Impact factor: 2.980

4.  Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis.

Authors:  Je-Min Choi; Seung-Hyung Kim; Jae-Hoon Shin; Thomas Gibson; Byoung-Seok Yoon; Dong-Ho Lee; Seung-Kyou Lee; Alfred L M Bothwell; Jong-Soon Lim; Sang-Kyou Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

5.  [Recommendations of the German Society for Rheumatology on the perioperative approach under therapy with DMARDs and biologicals in inflammatory rheumatic diseases].

Authors:  K Krüger; K Albrecht; S Rehart; R Scholz
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

6.  Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery.

Authors:  Martin Fuerst; Henrike Möhl; Kerstin Baumgärtel; Wolfgang Rüther
Journal:  Rheumatol Int       Date:  2006-05-31       Impact factor: 2.631

7.  Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement.

Authors:  Beverly K Johnson; Susan M Goodman; Michael M Alexiades; Mark P Figgie; Ryan T Demmer; Lisa A Mandl
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

Review 8.  Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence.

Authors:  Leslie Goh; Teresa Jewell; Catherine Laversuch; Ash Samanta
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

9.  Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Brent J Morris; David Mannino; Andrew Hoellein; Ryan P Donegan; Leslie J Crofford
Journal:  Semin Arthritis Rheum       Date:  2016-08-24       Impact factor: 5.532

Review 10.  Perioperative management of the patient with rheumatoid arthritis.

Authors:  Megan L Krause; Eric L Matteson
Journal:  World J Orthop       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.